KG
TXG icon

Kilter Group’s 10x Genomics TXG Stock Holding History

Kilter Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.36K Hold
244
– – ﹤0.01% 490
2026
Q1 		$5.18K Hold
244
– – ﹤0.01% 608
2025
Q4 		$3.98K Sell
244
-10
-4% -$151 ﹤0.01% 568
2025
Q3 		$2.97K Hold
254
– – ﹤0.01% 566
2025
Q2 		$2.94K Buy
+254
New +$2.31K ﹤0.01% 518

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kilter Group's TXG Position: Q2 2026 in Review

Kilter Group held its 10x Genomics (TXG) position steady in Q2 2026 at 244 shares worth $9.36K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Kilter Group first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Kilter Group held 244 shares of 10x Genomics worth $9.36K as of Q2 2026.
  • Kilter Group left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #490 holding.
  • Kilter Group first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.